1. Home
  2. EVAX vs FUSE Comparison

EVAX vs FUSE Comparison

Compare EVAX & FUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evaxion Biotech

EVAX

Evaxion Biotech

HOLD

Current Price

$3.24

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Logo Fusemachines Inc.

FUSE

Fusemachines Inc.

HOLD

Current Price

$0.83

Market Cap

28.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVAX
FUSE
Founded
2008
2013
Country
Denmark
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
25.9M
28.6M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
EVAX
FUSE
Price
$3.24
$0.83
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$11.67
N/A
AVG Volume (30 Days)
11.4K
3.4M
Earning Date
05-07-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
96.38
EPS
N/A
N/A
Revenue
N/A
$7,714,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$328.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.52
$0.75
52 Week High
$12.15
$3.67

Technical Indicators

Market Signals
Indicator
EVAX
FUSE
Relative Strength Index (RSI) 61.23 44.97
Support Level $2.93 $0.82
Resistance Level $3.61 $1.93
Average True Range (ATR) 0.16 0.17
MACD 0.06 0.00
Stochastic Oscillator 83.61 8.23

Price Performance

Historical Comparison
EVAX
FUSE

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

About FUSE Fusemachines Inc.

Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.

Share on Social Networks: